The company raised 2,2 MSEK from local business angels in a private funding round.Spring 2020
Microsensor project (Swelife)Chronic pain is the second biggest cost driver in the world in healthcare.
The aim of the project is to develop an innovative In Vivo sensor for identification and localization of deeply located musculoskeletal tissue anomalies (painsources) in patients with chronic pain.
Ultimately our goal is to measure and objectify pain.
Linköping UniversityA qualitative study in elite track and field published
Clinical expansionOur clinical expansion requires more clinicians to strengthen our team and at the same time confirm clinical scalability.